Biotech can be one of the most rewarding sectors in the market.. [SA.]( [Divider] Biotech can be one of the most rewarding sectors in the market. In fact, the list of 2024's best stocks is peppered with biotech names. Like Viking Therapeutics, up 210% this year alone. Or Arcutis Biotherapeutics, up 212% already in 2024. Janux Therapeutics is up 210% so far this year. [But there's only one problem â¦]( Unless you have a PhD ⦠Or an inside source ⦠Good luck picking biotech winners ahead of time. The FDA approval process is extremely difficult. It can cost billions of dollars ⦠And last more than a decade. Even then, after multiple phases of trials, a drug can still be rejected. In fact, 9 in 10 drugs never get approval from the FDA. They die on the vine. And even for the ones who survive, it can be hard to get any information on the status of a drug ⦠Or how close it is to approval. The FDA is notoriously opaque. [But for a special set of drug companies, all of that has changed.]( The FDA has started to quietly send out a signal. This signal means specific companies will get an expedited route to approval ⦠And hands-on guidance from the FDA. For investors, there's something even more important going on here ⦠Over 97% of the time the FDA sends out this signal ⦠The company involved has seen its stock spike sometime in the following months. 74 out of 76 times since 2016. For an average gain of 117% in just eight months. And it has nothing to do with approval or rejection. Take Adaptimmune Therapeutics, for example.
[Chart](
Shares were hovering around one dollar when the FDA sent out this quiet signal on Adaptimmune's new tumor drug. Within six months, the stock shot up 845% It took almost four more years before the drug was approved.
[Chart](
Caladrius Biosciences' stock was going nowhere, stuck around $4 ⦠Then it got this FDA signal. And shares jumped 119% â in two days. The drug in question wasn't approved for another five years â¦
[Chart](
Ocugen received an FDA signal in December 2023. Its share price spiked 435% in just five months. The drug has yet to be given final approval. It's a simple trade. The FDA sends out this signal. And 97% of the time the company's stock price has gone up in the following months. And whether the drug was eventually approved or not had no effect ⦠[Now, I believe one drug company is on the verge of getting this FDA signal.]( In fact, I think it could happen very soon ⦠[That's why I just put together an important video with all the details on this incredible signal â and the stock market winners it's produced.]( Sincerely, Michael Robinson, Editor
Disruptors & Dominators [Divider] At Simple Attachments, we are serious about being your âeyes and earsâ for special opportunities for you to take advantage of. The message above from one of our partners is one we think you should take a close look at. This email was sent to you by Simple Attachments on behalf of Ðvent Horizon LLC.
435 N Dupont Hwy, Dover, DE 19901, United States 11780 US Highway 1,
Palm Beach Gardens, FL 33408-3080
Would you like to [edit your e-mail notification preferences or unsubscribe]( from our mailing list?
Copyright © 2024 Weiss Ratings. All rights reserved. Need assistance? Our dedicated support team is just a click away! [Connect with us](mailto:support@simpleattachments.com) now for a seamless experience.
Copyright © 2024 All Rights Reserved [Privacy policy](
[Terms & Conditions](
[Unsubscribe]( [Logotype](urlhere) веÑÑ
ÑвоÑÑ
оÑей надÑвав ÑаÑом Ñе й кÑпованÑ. ÐаÑе вже, коли завÑÑаÑÑе в гоÑÑÑ, Ñо Ð´Ð¸Ð½Ñ Ð¿Ð¾Ð´Ð°Ð¼Ð¾ ÑакиÑ
, ÑкиÑ
ви зÑодÑ, може, не Ñли; а медÑ, Ñ Ð·Ð°Ð±Ð¾Ð¶ÑÑÑ, кÑаÑого не знайдеÑе на Ñ
ÑÑоÑаÑ
. ÐодÑмайÑе ÑобÑ, Ñо, Ñк внеÑÐµÑ ÑÑлÑник â запаÑ
пÑде по вÑÑй кÑмнаÑÑ, ÑÑвиÑи ÑÐ¾Ð±Ñ Ð½Ðµ можна, Ñкий: ÑиÑÑий, Ñк ÑлÑоза, або кÑиÑÑÐ°Ð»Ñ Ð´Ð¾Ñогий, Ñо бÑÐ²Ð°Ñ Ð² ÑеÑгаÑ
. Ð Ñкими пиÑогами нагодÑÑ Ð¼Ð¾Ñ ÑÑаÑа! Що Ñо за пиÑоги, Ñкби ви ÑÑлÑки знали! ÑаÑ
аÑ, ÑпÑавжнÑÑÑнÑкий ÑаÑ
аÑ! РмаÑло, Ñак-Ð¾Ñ Ñ ÑеÑе по гÑбаÑ
, коли поÑÐ½ÐµÑ ÑÑÑи. ÐодÑмаÑÑ ÑпÑавдÑ: на Ñо ÑÑлÑки не майÑÑеÑниÑÑ ÑÑ Ð±Ð°Ð±Ð¸! Чи ви пили коли-небÑдÑ, панове, гÑÑÑовий ÐºÐ²Ð°Ñ Ð· ÑеÑновими Ñгодами, або ваÑÐµÐ½Ñ Ð· Ñодзинками Ñа Ñливами? Ðбо, Ñи не ÑÑаплÑлоÑÑ Ð²Ð°Ð¼, ÑаÑом, ÑÑÑи пÑÑÑÑ[8] з молоком? Ðоже Ñи мÑй, ÑкиÑ
на ÑвÑÑÑ Ð½ÐµÐ¼Ð° ÑÑÑав! ÐоÑÐ½ÐµÑ ÑÑÑи â пÑоÑÑо наÑолода Ñа й годÑ. Ð¢Ð°ÐºÑ ÑмаÑнÑ, Ñо й не опиÑаÑи! ÐинÑлого ÑокÑ⦠ÐÑоÑе, Ñо Ñе Ñ, ÑпÑавдÑ, ÑозбалакавÑÑ?.. ÐÑиÑздÑÑÑ ÑÑлÑки, пÑиÑздÑÑÑ ÑвидÑе; а нагодÑÑмо Ñак, Ñо бÑдеÑе ÑозказÑваÑи ÐºÐ¾Ð¶Ð½Ð¾Ð¼Ñ ÑÑÑÑÑномÑ. ÐаÑÑÑник Ð Ñдий ÐанÑко Ðа вÑÑкий випадок, Ñоб не Ñпом'ÑнÑли мене недобÑим Ñловом, випиÑÑÑ ÑÑди, в азбÑÑÐ½Ð¾Ð¼Ñ Ð¿Ð¾ÑÑдкÑ, ÑÑ Ñлова, ÑÐºÑ Ð² книжÑÑ ÑÑй не вÑÑÐºÐ¾Ð¼Ñ Ð·ÑозÑмÑлÑ[9]. СоÑоÑинÑÑкий ÑÑмаÑок I ÐÐµÐ½Ñ Ð½Ñдно в Ñ
аÑÑ Ð¶Ð¸ÑÑ. Ðй, вези ж мене Ñз домÑ, Ðе багаÑÑко гÑомÑ, гÑомÑ, Ðе гопÑÑÑÑÑ Ð²Ñе дÑвки, Ðе гÑлÑÑÑÑ Ð¿Ð°ÑÑбки! ÐÑ ÑÑаÑÐ¾Ð²Ð¸Ð½Ð½Ð¾Ñ Ð»ÐµÐ³ÐµÐ½Ð´Ð¸ Який ÑаÑÑвний, Ñкий ÑозкÑÑний лÑÑнÑй Ð´ÐµÐ½Ñ Ñ ÐалоÑоÑÑÑ! Ð¯ÐºÑ Ð¼Ð»Ð¾ÑногаÑÑÑÑ ÑÑ Ð³Ð¾Ð´Ð¸Ð½Ð¸, коли полÑÐ´ÐµÐ½Ñ ÑÑÑ ÑеÑед ÑиÑÑ Ð¹ Ñпеки, Ñ Ð±Ð»Ð°ÐºÐ¸Ñний, незмÑÑний океан, жагÑÑим кÑполом ÑÑ
иливÑиÑÑ Ð½Ð°Ð´ землеÑ, здаÑÑÑÑÑ, заÑнÑв, веÑÑ Ð¿Ð¾ÑонÑвÑи в млоÑÑÑ, пÑигоÑÑаÑÑи й ÑÑиÑкаÑÑи пÑекÑаÑÐ½Ñ Ð² нÑжниÑ
обÑймаÑ
ÑвоÑÑ
! Ðа нÑÐ¾Ð¼Ñ Ð½Ñ Ñ
маÑинки. Ð Ð¿Ð¾Ð»Ñ Ð½Ñ Ð·Ð²ÑкÑ. ÐÑе наÑебÑо вимеÑло; вгоÑÑ ÑÑлÑки в небеÑнÑй Ð³Ð»Ð¸Ð±Ð¸Ð½Ñ ÑÑемÑиÑÑ Ð¶Ð°Ð¹Ð²Ð¾Ñонок, Ñ ÑÑÑÐ±Ð½Ñ Ð¿ÑÑÐ½Ñ Ð»ÐµÑÑÑÑ Ð¿Ð¾Ð²ÑÑÑÑними ÑÑ
одами на закоÑ
Ð°Ð½Ñ Ð·ÐµÐ¼Ð»Ñ, Ñа зÑÑдка ÐºÐ¸Ð³Ð¸ÐºÐ°Ð½Ð½Ñ Ñайки Ñи дзвÑнкий Ð³Ð¾Ð»Ð¾Ñ Ð¿ÐµÑепела пÑолÑÐ½Ð°Ñ Ð² ÑÑепÑ. ÐÑниво й бездÑмно, нÑби гÑлÑÑÑи без меÑи, ÑÑоÑÑÑ Ð¿ÑдÑ
маÑÐ½Ñ Ð´Ñби, Ñ ÑлÑпÑÑÑ ÑдаÑи ÑонÑÑного пÑомÑÐ½Ð½Ñ Ð·Ð°Ð¿Ð°Ð»ÑÑÑÑ ÑÑÐ»Ñ Ð¼Ð°Ð»ÑовниÑÑ Ð¼Ð°Ñи лиÑÑÑ, кидаÑÑи на ÑнÑÑ ÑемнÑ, Ñк нÑÑ, ÑÑнÑ, на ÑÐºÑ ÑÑлÑки пÑи Ð²ÐµÐ»Ð¸ÐºÐ¾Ð¼Ñ Ð²ÑÑÑÑ Ð±ÑÐ¸Ð·ÐºÐ°Ñ Ð·Ð¾Ð»Ð¾Ñо. СмаÑагди, Ñопази, ÑÑ
онÑи еÑÑÑниÑ
комаÑ
ÑиплÑÑÑÑÑ Ð½Ð°Ð´ баÑвиÑÑими гоÑодами, обÑамованими ÑÑÑÑнкими ÑонÑÑниками. СÑÑÑ ÑкиÑÑи ÑÑна й золоÑÑ Ñнопи Ñ
лÑба ÑабоÑом ÑозÑаÑовÑÑÑÑÑÑ Ð² Ð¿Ð¾Ð»Ñ Ð¹ коÑÑÑÑÑ Ð¿Ð¾ його безкÑайноÑÑÑ.